A new study has demonstrated that using the ‘wisdom of crowds’ (also known as collective intelligence) of three […]

Bayer, ViiV and RB challenge limits of pharma marketing creativity with innovative thinking, executions and media bbulik Mon, […]

Gilead won a valuable FDA voucher with its Veklury approval, but patient advocates are urging the company to […]

Older patients are typically sedentary, you assume—without realising it. A patient you relate to well receives that bit […]

Obesity management treatment recommended following confidential discount

Data presented at virtual European Academy of Dermatology and Venereology congress

Partnership aims to advance disease severity testing programme for COVID-19

Gilead and Galapagos’ application for oral JAK1 inhibitor validated by agency

Updated Date: Mon, 26 Oct 2020 00:00:00 EDT

Updated Date: Mon, 26 Oct 2020 00:00:00 EDT